Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by u2bobon Feb 20, 2018 3:15pm
147 Views
Post# 27589392

RE:RE:RE:ADK...Aready doing DR...Next Stop Cardio !

RE:RE:RE:ADK...Aready doing DR...Next Stop Cardio !
emiltech wrote:
Google is not alone in this field.

Amazon, Tencent, Alibaba, MSFT, IBM, Appl, and you can name all of the big players in the heath care business. Europe is a leader in this field.

All of them will need big data. Data collected under controlled experiments. That is where ADK comes in the puzzle!


To me it looks like one big issue time to market when dealing with FDA ...none of the big guys want to wait... they will buy out companies like ADK who have done leg work with Big Pharma and proven pilots...the more advances that ADK makes the more chances of a JV fundus camera maker or medical imaging equipment makers... all needing to move into the future with AI software...Until then keep lining up contracts and R&D ...

Good luck...
Bob
Bullboard Posts